Directly observed therapy for HIV/tuberculosis co-infection.
Lurie
Mark N
MN
International Health Institute, Brown University Medical School and the Miriam Hospital, Providence, Rhode Island 02912, USA. Mark_lurie@brown.edu
Carter
E Jane
EJ
Cohen
Jonathan
J
Flanigan
Timothy P
TP
D017954:Africa South of the Sahara / Q000453:epidemiology; D044966:Anti-Retroviral Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000458:organization & administration*; D003906:Developing Countries; D023801:Directly Observed Therapy; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D010342:Patient Acceptance of Health Care; D010349:Patient Compliance; D015995:Prevalence; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology
D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents